Form 4 for MLYS Mineralys Therapeutics, Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-09 · accession 0001672659-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-10 | 2026-03-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 84.7K | +3% | +$34.7K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.84 | -2,171 | 82.5K | -3% | -$58.3K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.00 | -2,171 | 23.9K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | M | A | 2,171 | $16.00 | 84,660 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-09 | S | D | 2,171 | $26.84 | 82,489 | D | — | — | |
| 3 | Derivative | Stock Option | 2026-03-09 | M | D | 2,171 | $0.00 | 23,876 | D | $16.00 · — to 2033-02-09 | 2,171 Common Stock | (F2) The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter. |